BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14563516)

  • 1. Thrombocytopenia and hemorrhagic risk in cancer patients.
    Avvisati G; Tirindelli MC; Annibali O
    Crit Rev Oncol Hematol; 2003 Oct; 48(Suppl):S13-6. PubMed ID: 14563516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of bleeding and prophylactic platelet transfusions in cancer patients with thrombocytopenia.
    Vinholt PJ; Alnor A; Nybo M; Hvas AM
    Platelets; 2016 Sep; 27(6):547-54. PubMed ID: 27025360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
    Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N
    Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions.
    Friedmann AM; Sengul H; Lehmann H; Schwartz C; Goodman S
    Transfus Med Rev; 2002 Jan; 16(1):34-45. PubMed ID: 11788928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enoxaparin dose reduction for thrombocytopenia in patients with cancer: a quality assessment study.
    Mantha S; Miao Y; Wills J; Parameswaran R; Soff GA
    J Thromb Thrombolysis; 2017 May; 43(4):514-518. PubMed ID: 28205078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders.
    Wardrop D; Estcourt LJ; Brunskill SJ; Doree C; Trivella M; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Jul; (7):CD009733. PubMed ID: 23897323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New strategies for the optimal use of platelet transfusions.
    Blajchman MA; Slichter SJ; Heddle NM; Murphy MF
    Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding due to thrombocytopenia in acute leukemias and reevaluation of the prophylactic platelet transfusion policy.
    Aderka D; Praff G; Santo M; Weinberger A; Pinkhas J
    Am J Med Sci; 1986 Mar; 291(3):147-51. PubMed ID: 3456706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet transfusions and bleeding complications associated with plasma exchange catheter placement in patients with presumed thrombotic thrombocytopenic purpura.
    Duffy SM; Coyle TE
    J Clin Apher; 2013 Oct; 28(5):356-8. PubMed ID: 23720092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic platelet transfusion in children with thrombocytopenic disorders: a retrospective review.
    Ferrara M; Capozzi L; Coppola A; Save G; Coppola L
    Hematology; 2007 Aug; 12(4):297-9. PubMed ID: 17654055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the proper threshold for platelet transfusion in patients with chemotherapy-induced thrombocytopenia?
    Benjamin RJ; Anderson KC
    Crit Rev Oncol Hematol; 2002 May; 42(2):163-71. PubMed ID: 12007974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How well do platelets prevent bleeding?
    Triulzi DJ
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):518-522. PubMed ID: 33275687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients.
    Drews RE
    Clin Chest Med; 2003 Dec; 24(4):607-22. PubMed ID: 14710693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet transfusion trigger in difficult patients.
    Rebulla P
    Transfus Clin Biol; 2001 Jun; 8(3):249-54. PubMed ID: 11499971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of hemorrhagic complications in patients with cancer.
    Belt RJ; Leite C; Haas CD; Stephens RL
    JAMA; 1978 Jun; 239(24):2571-4. PubMed ID: 660790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between platelet count and bleeding risk in thrombocytopenic patients.
    Slichter SJ
    Transfus Med Rev; 2004 Jul; 18(3):153-67. PubMed ID: 15248165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet transfusion in hematology, oncology and surgery.
    Wandt H; Schäfer-Eckart K; Greinacher A
    Dtsch Arztebl Int; 2014 Nov; 111(48):809-15. PubMed ID: 25512006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of thrombocytopenia and serious hemorrhage among patients with solid tumors.
    Dutcher JP; Schiffer CA; Aisner J; O'Connell BA; Levy C; Kendall JA; Wiernik PH
    Cancer; 1984 Feb; 53(3):557-62. PubMed ID: 6692260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triggers for prophylactic use of platelet transfusions and optimal platelet dosing in thrombocytopenic dogs and cats.
    Abrams-Ogg AC
    Vet Clin North Am Small Anim Pract; 2003 Nov; 33(6):1401-18. PubMed ID: 14664205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of efficacy of prophylactic platelet transfusion for severe thrombocytopenia in adults with acute uncomplicated dengue infection.
    Lye DC; Lee VJ; Sun Y; Leo YS
    Clin Infect Dis; 2009 May; 48(9):1262-5. PubMed ID: 19292665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.